Clover Health Investments, Corp.
CLOV
$0.6445
$0.00170.26%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -44.51% | -45.85% | -41.26% | -41.74% | 145.85% |
| Total Other Revenue | -7.52% | 82.16% | 1,531.59% | -64.21% | 107.35% |
| Total Revenue | -44.31% | -45.47% | -40.57% | -42.07% | 145.61% |
| Cost of Revenue | -49.87% | -50.11% | -49.12% | -45.17% | 102.21% |
| Gross Profit | 281.42% | 44.13% | 477.65% | 8.70% | 121.24% |
| SG&A Expenses | -11.60% | -13.27% | -10.77% | 2.08% | 9.00% |
| Depreciation & Amortization | 180.14% | -9.58% | 70.48% | -66.22% | -199.17% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -45.09% | -45.55% | -44.43% | -39.13% | 82.67% |
| Operating Income | 51.64% | 46.51% | 76.86% | 3.30% | 42.01% |
| Income Before Tax | 16.33% | 45.07% | 72.39% | 3.82% | 55.01% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 16.33% | 45.07% | 72.39% | 3.82% | 55.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.33% | 45.07% | 72.39% | 3.82% | 55.01% |
| EBIT | 51.64% | 46.51% | 76.86% | 3.30% | 42.01% |
| EBITDA | 51.83% | 46.82% | 77.69% | 2.60% | 41.89% |
| EPS Basic | 16.97% | 45.38% | 72.58% | 5.01% | 60.43% |
| Normalized Basic EPS | 51.60% | 47.17% | 77.08% | 4.91% | 49.44% |
| EPS Diluted | 16.97% | 45.38% | 72.58% | 5.01% | 60.43% |
| Normalized Diluted EPS | 51.60% | 47.17% | 77.08% | 4.91% | 49.44% |
| Average Basic Shares Outstanding | 0.78% | 0.64% | 0.65% | 1.22% | 13.67% |
| Average Diluted Shares Outstanding | 0.78% | 0.64% | 0.65% | 1.22% | 13.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
